South America Blood Grouping Reagents Market

South America Blood Grouping Reagents Market Research Report By Product (Consumables, Instruments), By Technique (PCR-based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology), By Test Type (Blood Group and Phenotypes, Antibody Screening, Crossmatching Tests, Antibody Identification, Coombs’s Test, Antigen Typing), By End User (Hospitals, Blood Banks, Clinical Laboratories) and By Regional (Brazil, Mexico, Argentina, Rest of South America) -Forecast to 2035

Forecast Period
2025 - 2035
CAGR
7.51%
2024 Market Size
$ 0.21 Million
2035 Market Size
$ 0.46 Million
Medical Device ● Updated August 2026 Report ID: MRFR/MED/51494-HCR | Pages: 200 | Author: Rahul Gotadki
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Chemicals and Materials, BY Product (USD Million)
      1. 4.1.1 Consumables
      2. 4.1.2 Instruments
    2. 4.2 Chemicals and Materials, BY Technique (USD Million)
      1. 4.2.1 PCR-based and Microarray Technique
      2. 4.2.2 Assay-Based Techniques
      3. 4.2.3 Massively Parallel Sequencing Techniques
      4. 4.2.4 Serology
      5. 4.2.5 Other Techniques
    3. 4.3 Chemicals and Materials, BY Test Type (USD Million)
      1. 4.3.1 Blood Group and Phenotype
      2. 4.3.2 Antibody Screening
      3. 4.3.3 Cross-matching Tests
      4. 4.3.4 Antibody Identification
      5. 4.3.5 Coombs Tests
      6. 4.3.6 Antigen Typing
    4. 4.4 Chemicals and Materials, BY End User (USD Million)
      1. 4.4.1 Hospitals
      2. 4.4.2 Blood Banks
      3. 4.4.3 Clinical Laboratories
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Abbott Laboratories (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Thermo Fisher Scientific (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Siemens Healthineers (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Bio-Rad Laboratories (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Ortho Clinical Diagnostics (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Grifols (ES)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Beckman Coulter (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Merck KGaA (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 F. Hoffmann-La Roche (CH)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY PRODUCT
    3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY TECHNIQUE
    4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE
    5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY END USER
    6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    12. 6.12 CHEMICALS AND MATERIALS, BY PRODUCT, 2024 (% SHARE)
    13. 6.13 CHEMICALS AND MATERIALS, BY PRODUCT, 2024 TO 2035 (USD Million)
    14. 6.14 CHEMICALS AND MATERIALS, BY TECHNIQUE, 2024 (% SHARE)
    15. 6.15 CHEMICALS AND MATERIALS, BY TECHNIQUE, 2024 TO 2035 (USD Million)
    16. 6.16 CHEMICALS AND MATERIALS, BY TEST TYPE, 2024 (% SHARE)
    17. 6.17 CHEMICALS AND MATERIALS, BY TEST TYPE, 2024 TO 2035 (USD Million)
    18. 6.18 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
    19. 6.19 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million)
      2. 7.2.2 BY TECHNIQUE, 2025-2035 (USD Million)
      3. 7.2.3 BY TEST TYPE, 2025-2035 (USD Million)
      4. 7.2.4 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

South America South America Blood Grouping Reagents Market Segmentation

South America Blood Grouping Reagents Market By Product (USD Million, 2025-2035)

  • Consumables
  • Instruments

South America Blood Grouping Reagents Market By Technique (USD Million, 2025-2035)

  • PCR-based and Microarray Technique
  • Assay-Based Techniques
  • Massively Parallel Sequencing Techniques
  • Serology
  • Other Techniques

South America Blood Grouping Reagents Market By Test Type (USD Million, 2025-2035)

  • Blood Group and Phenotype
  • Antibody Screening
  • Cross-matching Tests
  • Antibody Identification
  • Coombs Tests
  • Antigen Typing

South America Blood Grouping Reagents Market By End User (USD Million, 2025-2035)

  • Hospitals
  • Blood Banks
  • Clinical Laboratories
Share::
WhatsApp icon
LinkedIn icon
X (Twitter) icon
ChatGPT icon
Perplexity icon
Request Free Sample

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.